Experimental cancer drug THOR-707 tested in patients with advanced tumors
Disease control
Terminated
This study tested an experimental drug called THOR-707 in adults with advanced solid tumors that had spread. The goal was to find safe doses and see if the drug could shrink tumors when used alone or with other treatments. The study was stopped early, so results are limited.
Phase: PHASE1, PHASE2 • Sponsor: Synthorx, Inc, a Sanofi company • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC